Eli Lilly | Capital Ordinário



Ordinary Share Capital Alterar Data
AbbVie USD 18M 0 2024-12
Abbott USD 25.12B 28M 2025-03
ALKERMES USD 165.05M 163.25M 2025-06
Amgen USD 538M 33.04B 2025-06
AstraZeneca USD 1.55B 1.16B 2025-06
Baxter International USD 683M 0 2024-12
Biogen USD 146.6M 146.5M 2025-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
Drreddys Laboratories INR 834M 0 2024-12
Eli Lilly USD 946.83M 354.23M 2025-06
Gilead Sciences USD 1.24B 3M 2025-06
GlaxoSmithKline GBP 4.15B 2.8B 2025-06
Glaxosmithkline GBP 1.35B 0 2024-12
J&J USD 3.12B 0 2025-03
Medtronic USD 128K 128K 2025-04
Merck USD 1.79B 0 2025-03
Neurocrine Biosciences USD 99M 0 2025-06
Novartis USD 793M 0 2024-12
Novartis USD 793M 0 2024-12
Novo Nordisk 4.44B 3.99B 2025-06
Perrigo USD 137.6M 6.56B 2025-06
Pfizer USD 5.68B 5.2B 2025-06
Prestige Brands USD 49.21M 48.65M 2025-06
Regeneron Pharmaceuticals USD 106.4M 106.4M 2025-06
Roche Holding CHF 107M 0 2024-06
Sanofi 1.22B 36.5M 2025-06
Sanofi 1.25B 52.53M 2025-03
United Therapeutics USD 45.22M 44.42M 2025-06
Zoetis USD 443.95M 438.95M 2025-06


Eli Lilly Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.